Endoprotech

Developer of liposome-based therapies for myocardial infarction and alcohol liver disease

placeLouisville, Kentucky, United States calendar_todayFounded 2005 groups4 employees language endoprotech.com

Innovation

1 patent family (1 granted) — focus: Human necessities; filing pace steady. Cited 141 times.

YearFilings
20201
20211
20231
20241
20251

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%
Coming soon